{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:05:11Z","timestamp":1764493511453},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2005,2,24]],"date-time":"2005-02-24T00:00:00Z","timestamp":1109203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,2,24]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The non-specific acute phase response in mice is associated with increased resistance to bacterial infection, which is critically mediated by granulocyte colony stimulating factor (G-CSF), but the behaviour of G-CSF in the human acute phase response is not known. Cardiothoracic surgery is a powerful acute phase stimulus and we show here that this procedure caused increased production of G-CSF, in addition to increases in the circulating concentrations of the proinflammatory cytokine interleukin (IL)-6 and the acute phase plasma proteins C-reactive protein (CRP) and serum amyloid A protein (SAA). Values of G-CSF correlated positively with IL-6 concentrations and circulating neutrophil counts, but not with CRP values. These results confirm that G-CSF is a physiological component of the acute phase response in humans that shares some of the same regulatory controls as IL-6, but its downstream effects are on neutrophils, not hepatic acute phase protein synthesis. Our observations are compatible with a protective role against bacterial infection for G-CSF in the human acute phase response, and support investigation of the prophylactic use of G-CSF in at-risk patients.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02732.x","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T11:50:33Z","timestamp":1110541833000},"page":"97-100","source":"Crossref","is-referenced-by-count":17,"title":["Relationship of granulocyte colony stimulating factor with other acute phase reactants in man"],"prefix":"10.1093","volume":"140","author":[{"given":"M","family":"Noursadeghi","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Microbiology, Imperial College School of Medicine, Hammersmith Hospital, London"},{"name":"Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M B","family":"Pepys","sequence":"additional","affiliation":[{"name":"Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gallimore","sequence":"additional","affiliation":[{"name":"Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Microbiology, Imperial College School of Medicine, Hammersmith Hospital, London"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"2022010818041665600_b1","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V78.11.2791.bloodjournal78112791","article-title":"Granulocyte colony-stimulating factor and its receptor","volume":"78","author":"Demetri","year":"1991","journal-title":"Blood"},{"key":"2022010818041665600_b2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.169.2.913","article-title":"Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection","volume":"169","author":"Noursadeghi","year":"2002","journal-title":"J Immunol"},{"key":"2022010818041665600_b3","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1128\/IAI.72.8.4647-4653.2004","article-title":"Attenuation of the bacterial load in blood by pretreatment with granulocyte-colony-stimulating factor protects rats from fatal outcome and brain damage during Streptococcus pneumoniae meningitis","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"key":"2022010818041665600_b4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/317652","article-title":"Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia. effects of lung inflammation and timing of treatment","volume":"183","author":"Dallaire","year":"2001","journal-title":"J Infect Dis"},{"key":"2022010818041665600_b5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/515694","article-title":"A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia","volume":"178","author":"Nelson","year":"1998","journal-title":"J Infect Dis"},{"key":"2022010818041665600_b6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/AAC.45.4.1094-1098.2001","article-title":"Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection","volume":"45","author":"De Lalla","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2022010818041665600_b7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.CCM.0000048629.32625.5D","article-title":"Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis","volume":"31","author":"Root","year":"2003","journal-title":"Crit Care Med"},{"key":"2022010818041665600_b8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajh.2830410309","article-title":"Serum granulocyte colony-stimulating factor in patients with repeated infections","volume":"41","author":"Kawakami","year":"1992","journal-title":"Am J Hematol"},{"key":"2022010818041665600_b9","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1182\/blood.V76.10.1962.1962","article-title":"Levels of serum granulocyte colony-stimulating factor in patients with infections","volume":"76","author":"Kawakami","year":"1990","journal-title":"Blood"},{"key":"2022010818041665600_b10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.1994.tb05015.x","article-title":"Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia","volume":"88","author":"Pauksen","year":"1994","journal-title":"Br J Haematol"},{"key":"2022010818041665600_b11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2044.1986.tb12696.x","article-title":"C-reactive protein in patients undergoing cardiac surgery","volume":"41","author":"Boralessa","year":"1986","journal-title":"Anaesthesia"},{"key":"2022010818041665600_b12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S1047951103000301","article-title":"Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children.","volume":"13","author":"Beghetti","year":"2003","journal-title":"Cardiology in the Young"},{"key":"2022010818041665600_b13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/bja\/83.4.602","article-title":"Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations","volume":"83","author":"Aouifi","year":"1999","journal-title":"Br J Anaesth"},{"key":"2022010818041665600_b14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03019820","article-title":"Neutrophilia and granulocyte colony-stimulating factor levels after cardiopulmonary bypass","volume":"48","author":"Iwasaka","year":"2001","journal-title":"Can J Anaesth"},{"key":"2022010818041665600_b15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0009-8981(95)06105-M","article-title":"New aspects concerning the regulation of the post-operative acute phase reaction during cardiac surgery","volume":"239","author":"Berger","year":"1995","journal-title":"Clin Chim Acta"},{"key":"2022010818041665600_b16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/000331970005100906","article-title":"Endotoxemia and mediator release during cardiac surgery","volume":"51","author":"Boelke","year":"2000","journal-title":"Angiology"},{"key":"2022010818041665600_b17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1399-6576.2001.045004407.x","article-title":"Cardiopulmonary bypass elicits a pro- and anti-inflammatory cytokine response and impaired neutrophil chemotaxis in neonatal pigs","volume":"45","author":"Brix-Christensen","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"2022010818041665600_b18","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.CIR.96.10.3542","article-title":"Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia","volume":"96","author":"Bruins","year":"1997","journal-title":"Circulation"},{"key":"2022010818041665600_b19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1053-0770(96)80052-8","article-title":"A study of the effects of extracorporeal circulation on the immunologic system of humans","volume":"10","author":"Siminelakis","year":"1996","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2022010818041665600_b20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/00365519909168324","article-title":"A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease","volume":"230","author":"Eda","year":"1999","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"2022010818041665600_b21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/000456329803500607","article-title":"Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum","volume":"35","author":"Ledue","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"2022010818041665600_b22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-3083.1999.00575.x","article-title":"Cytokine-mediated regulation of granulocyte colony-stimulating factor production","volume":"50","author":"Hannen","year":"1999","journal-title":"Scand J Immunol"},{"key":"2022010818041665600_b23","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.4049\/jimmunol.162.6.3519","article-title":"Modulation of endocytosis in nuclear factor IL-6(-\/-) macrophages is responsible for a high susceptibility to intracellular bacterial infection","volume":"162","author":"Pizarro-Cerda","year":"1999","journal-title":"J Immunol"},{"key":"2022010818041665600_b24","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/j.1460-2075.1990.tb08316.x","article-title":"A nuclear factor for IL-6 expression (NF-IL6) is a member of a C\/EBP family","volume":"9","author":"Akira","year":"1990","journal-title":"EMBO J"},{"key":"2022010818041665600_b25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1165\/ajrcmb\/9.3.255","article-title":"Lipopolysaccharide induces expression of granulocyte\/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract","volume":"9","author":"Xing","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022010818041665600_b26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2141.1994.tb04725.x","article-title":"Endogenous haemopoietic growth factors in neutropenia and infection","volume":"86","author":"Cebon","year":"1994","journal-title":"Br J Haematol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02732.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/1\/97\/42081241\/j.1365-2249.2005.02732.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/140\/1\/97\/42081241\/j.1365-2249.2005.02732.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T01:07:46Z","timestamp":1706058466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/140\/1\/97\/6440513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2005,2,24]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02732.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,4]]},"published":{"date-parts":[[2005,2,24]]}}}